Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Austen B, Casey"'
Autor:
Munmun Mukherjee, Ryan P. McGlynn, Meng Cui, Austen B. Casey, Stephen J. Kohut, Raymond G. Booth
Publikováno v:
British Journal of Pharmacology. 179:2610-2630
BACKGROUND AND PURPOSE The 5-HT receptor (5-HTR) subtypes 5-HT2A and 5-HT2C are important neurotherapeutic targets, though, obtaining selectivity over 5-HT2B and closely related histamine H1 Rs is challenging. Here, we delineated molecular determinan
Autor:
Daniel Ryskamp Rijsketic, Austen B. Casey, Daniel A. N. Barbosa, Xue Zhang, Tuuli M. Hietamies, Grecia Ramirez-Ovalle, Matthew B. Pomrenze, Casey H. Halpern, Leanne M. Williams, Robert C. Malenka, Boris D. Heifets
Publikováno v:
bioRxiv
The effects of context on the subjective experience of serotonergic psychedelics have not been fully examined in human neuroimaging studies, partly due to limitations of the imaging environment. Here, we administered saline or psilocybin to mice in t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7bbb028a2780211f796c748bbf4f67a4
https://europepmc.org/articles/PMC9980055/
https://europepmc.org/articles/PMC9980055/
Autor:
Jessica L Armstrong, Munmun Mukherjee, Tanishka S Saraf, Clinton E. Canal, Austen B. Casey, Raymond G. Booth
Publikováno v:
ACS Pharmacology & Translational Science. 3:509-523
Fragile X syndrome (FXS) is a neurodevelopmental disorder characterized by intellectual disabilities and a plethora of neuropsychiatric symptoms. FXS is the leading monogenic cause of autism spectrum disorder (ASD), which is defined clinically by rep
Publikováno v:
Biochem Pharmacol
Blockade of the serotonin 5-HT(2A) G protein-coupled receptor (5-HT(2A)R) is a fundamental pharmacological characteristic of numerous antipsychotic medications, which are FDA-approved to treat schizophrenia, bipolar disorder, and as adjunctive therap
Autor:
Austen B, Casey, Munmun, Mukherjee, Ryan P, McGlynn, Meng, Cui, Stephen J, Kohut, Raymond G, Booth
Publikováno v:
British journal of pharmacologyREFERENCES. 179(11)
The 5-HT receptor subtypes 5-HTWe synthesized 42 novel 4-PATs with halogen or aryl moieties at the C(4)-phenyl meta-position. Affinity, function, molecular modeling and 5-HTMost 4-PAT diastereomers in the (2S,4R)-configuration bound non-selectively t
Publikováno v:
Biochemical Pharmacology. 200:115028
Autor:
Charles K, Perry, Austen B, Casey, Daniel E, Felsing, Rajender, Vemula, Mehreen, Zaka, Noah B, Herrington, Meng, Cui, Glen E, Kellogg, Clinton E, Canal, Raymond G, Booth
Publikováno v:
Bioorganicmedicinal chemistry. 28(3)
The serotonin 5-HT
Autor:
Raymond G. Booth, Mehreen Zaka, Charles K. Perry, Daniel E. Felsing, Glen E. Kellogg, Meng Cui, Noah B. Herrington, Rajender Vemula, Clinton E. Canal, Austen B. Casey
Publikováno v:
Bioorganic & Medicinal Chemistry. 28:115262
The serotonin 5-HT7 G protein-coupled receptor (GPCR) is a proposed pharmacotherapeutic target for a variety of central and peripheral indications, albeit, there are no approved drugs selective for binding 5-HT7. We previously reported that a lead an
Autor:
Austen B. Casey, Clinton E. Canal
Publikováno v:
ACS chemical neuroscience. 8(6)
Aripiprazole was the first antipsychotic developed to possess agonist properties at dopamine D2 autoreceptors, a groundbreaking strategy that presented a new vista for schizophrenia drug discovery. The dopamine D2 receptor is the crucial target of al